The number of people experiencing cognitive decline is rising, and mild cognitive impairment (MCI) — a subtle reduction in memory or thinking abilities that doesn’t yet disrupt daily life — affects between 12% and 36% of adults over 65.
Those with MCI have an increased risk of progressing to dementia, including Alzheimer’s disease and vascular dementia, prompting researchers to investigate ways to slow or prevent these declines.
One of the most promising strategies involves citicoline, a nutritional ingredient increasingly studied for its ability to maintain and even improve cognitive function in those with age-related decline.
What Is Citicoline?
Citicoline (also known as CDP-choline) is a naturally occurring compound in the brain that supports healthy cell membranes, boosts energy production, and aids in neurotransmitter activity.
Available as a dietary supplement, citicoline breaks down into choline and cytidine once ingested, allowing these components to cross the blood-brain barrier and be used for brain structure and signaling.
While choline-rich foods can contribute to citicoline levels, supplementation offers unique benefits.
The Research Behind Citicoline
A 2023 systematic review examined seven clinical studies involving citicoline in individuals with MCI and dementia, including those with Alzheimer’s, vascular cognitive impairment, Parkinson’s-related MCI, and post-stroke cognitive issues.
The studies, which included roughly 213 participants each, followed individuals for nine months to two years, using tools like the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MOCA) to measure cognitive outcomes.
The results consistently showed positive effects:
- In vascular cognitive impairment, citicoline stabilized thinking and memory scores while those not taking it declined.
- In Alzheimer’s and mixed dementia, citicoline helped preserve (and sometimes slightly improve) cognitive function over time.
- In Parkinson’s-related MCI, participants experienced measurable improvements in memory and thinking after a year of use.
- Post-stroke, citicoline reduced the risk of developing long-term cognitive impairment.
Meta-analysis confirmed that citicoline produced a measurable improvement in overall cognitive scores.
Dosage and Supplementation
The most researched form of citicoline is Cognizin® at 500 milligrams per day. Many brain health supplements don’t include this full clinical dose, but it can be found in powders combined with creatine monohydrate or in capsules with resveratrol and kanna.
The Bottom Line
Citicoline demonstrates real potential for supporting cognitive health, particularly in the early stages of memory struggles with consistent, long-term use.
While it’s not a cure-all (lifestyle habits like diet, exercise, and sleep remain critical), citicoline may be a valuable addition to a comprehensive brain health strategy.
